Imatinib and Trametinib for KRAS-mutated Solid Tumor
Imatinib and Trametinib for KRAS-mutated Solid Tumor
Recruiting · NCT06962254 · Registry updated 2025-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Imatinib and Trametinib for KRAS-mutated Solid Tumor | Solid Tumor Cancer | Recruiting | Phase 1 | 2025-05-08 | NCT06962254 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| China Medical University Hospital | 112 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China Medical University Hospital | Taichung | Taiwan | 2 |